Search Results - "Athwal, Varinder S"

Refine Results
  1. 1
  2. 2

    The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study by Purssell, Huw, Bennett, Lucy, Street, Oliver, Hanley, Karen Piper, Hanley, Neil, Vasant, Dipesh H., Athwal, Varinder S.

    Published in Scientific reports (30-05-2023)
    “…Rome IV bowel disorders of gut brain interaction (DGBI) and non-alcoholic fatty liver disease (NAFLD) are highly prevalent entities with overlapping…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Epimorphin alters the inhibitory effects of SOX9 on Mmp13 in activated hepatic stellate cells by Pritchett, James, Athwal, Varinder S, Harvey, Emma, Martin, Katherine, Llewellyn, Jessica, Ireland, Philip, Nicolaides, Alexander, Humphries, Martin J, Bobola, Nicoletta, Hanley, Neil A, Piper Hanley, Karen

    Published in PloS one (27-06-2014)
    “…Liver fibrosis is a major cause of morbidity and mortality. It is characterised by excessive extracellular matrix (ECM) deposition from activated hepatic…”
    Get full text
    Journal Article
  6. 6

    Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools by Scott, Jennifer A., Jones, Andrew M., Jokl, Elliot, Gordon-Walker, Timothy, Barry, Peter J., Hanley, Neil A., Piper Hanley, Karen, Athwal, Varinder S.

    Published in Heliyon (01-11-2023)
    “…Cystic Fibrosis related liver disease (CFLD) is the 3rd largest cause of death in Cystic Fibrosis (CF). As advances in pulmonary therapies have increased…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis by Scott, Jennifer, Jones, Andrew M., Piper Hanley, Karen, Athwal, Varinder S.

    Published in Alimentary pharmacology & therapeutics (01-02-2022)
    “…Summary Background Cystic fibrosis‐related liver disease (CFLD) is the leading cause of death in cystic fibrosis (CF), after pulmonary disease. To improve…”
    Get full text
    Journal Article
  9. 9

    Emerging clinical perspectives in cystic fibrosis liver disease by Athwal, Varinder S., Scott, Jennifer A., Fitzpatrick, Emer, Rowland, Marion

    Published in Current opinion in pulmonary medicine (01-11-2021)
    “…Purpose of review Liver disease (CFLD) as a complication of cystic fibrosis is recognized as a more severe disease phenotype in both children and adults. We…”
    Get full text
    Journal Article
  10. 10

    Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications by Martin, Katherine, Hatab, Anas, Athwal, Varinder S., Jokl, Elliot, Piper Hanley, Karen

    Published in Current diabetes reports (01-03-2021)
    “…Purpose of Review Non-alcoholic fatty liver disease (NAFLD) is a major and increasing health burden, with the potential to overwhelm hepatology services…”
    Get full text
    Journal Article
  11. 11

    COVID-19 and hepatorenal syndrome by Wu, Henry H L, Athwal, Varinder S, Kalra, Philip A, Chinnadurai, Rajkumar

    Published in World journal of gastroenterology : WJG (21-10-2022)
    “…Coronavirus disease 2019 (COVID-19) is a highly infectious disease which emerged into a global pandemic. Although it primarily causes respiratory symptoms for…”
    Get full text
    Journal Article
  12. 12

    SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast function by Raza, Sayyid, Jokl, Elliot, Pritchett, James, Martin, Katherine, Su, Kim, Simpson, Kara, Birchall, Lindsay, Mullan, Aoibheann F, Athwal, Varinder S, Doherty, Daniel T, Zeef, Leo, Henderson, Neil C, Kalra, Philip A, Hanley, Neil A, Piper Hanley, Karen

    Published in Science signaling (02-03-2021)
    “…Renal fibrosis is a common end point for kidney injury and many chronic kidney diseases. Fibrogenesis depends on the sustained activation of myofibroblasts,…”
    Get more information
    Journal Article
  13. 13

    Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence? by Purssell, Huw, Whorwell, Peter J, Athwal, Varinder S, Vasant, Dipesh H

    Published in World journal of hepatology (27-12-2021)
    “…Irritable bowel syndrome (IBS) and non-alcoholic fatty liver disease (NAFLD) are amongst the most common gastrointestinal and liver conditions encountered in…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Secondary sclerosing cholangitis following extracorporeal membrane oxygenation for acute respiratory distress in polytrauma by Tunney, Ruth, Scott, Jennifer, Rudralingam, Velauthan, Liong, Sue, Athwal, Varinder S.

    Published in Clinical case reports (01-09-2018)
    “…Key Clinical Message Secondary sclerosing cholangitis is a recently identified phenomenon affecting the biliary tree. A subtype has been described in…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Mechanism of SOX9 Action as a Route to Diagnostic Strategies in Liver Fibrosis by Athwal, Varinder S

    Published 01-01-2013
    “…The work presented in this thesis aims to understand the role of the Sry-box transcription factor (SOX9) in liver fibrosis as a route to novel diagnostic…”
    Get full text
    Dissertation